Florent Robin

Title: Florent Robin: Innovator in Veterinary Pharmaceutical Formulations

Introduction

Florent Robin is a notable inventor based in Brussels, Belgium. He has made significant contributions to the veterinary medical sector through his innovative work in pharmaceutical formulations. His expertise and dedication to improving animal health have led to the development of a unique product that enhances medication compliance for pet owners.

Latest Patents

Florent Robin holds a patent for a pharmaceutical tablet formulation specifically designed for the veterinary medical sector. The patent, titled "Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof," focuses on a fixed-dose combination that includes an instable ACE inhibitor and pimobendan. This formulation is designed to ease the treatment and administration of medication, thereby improving compliance by reducing the number of tablets that need to be administered to animals. The innovative approach minimizes treatment failure rates and dosage mistakes, ultimately leading to better health outcomes for pets.

Career Highlights

Florent Robin is currently associated with Boehringer Ingelheim Vetmedica GmbH, where he continues to work on advancing veterinary medicine. His career is marked by a commitment to developing effective pharmaceutical solutions that address the needs of both animals and their owners.

Collaborations

Florent has collaborated with esteemed colleagues such as Martin Andreas Folger and Ragna Hoffmann. These partnerships have contributed to the successful development of his innovative pharmaceutical formulations.

Conclusion

Florent Robin's contributions to veterinary medicine through his patented pharmaceutical formulations demonstrate his commitment to improving animal health. His work not only benefits pets but also enhances the experience for pet owners, making medication administration more manageable.